Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial

NCT06256237 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Limited Stage Small Cell Lung Cancer

Interventions

DRUG: JS004
DRUG: Toripalimab
PROCEDURE: surgery
DRUG: Etoposide
DRUG: Platinum

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China